Platelets. 2006 Aug;17(5):296-302.

Reticulated platelets are increased in chronic myeloproliferative disorders, pure erythrocytosis, reactive thrombocytosis and prior to hematopoietic reconstitution after intensive chemotherapy.

Ryningen A, Apelseth T, Hausken T, Bruserud Ø.

Int J Cancer. 2006 Nov 15;119(10):2313-21.

Microvascular endothelial cells increase proliferation and inhibit apoptosis of native human acute myelogenous leukemia blasts.

Hatfield K, Ryningen A, Corbascio M, Bruserud O.

Clin Cancer Res. 2006 Jul 1;12(13):3985-92.

A distinct p53 protein isoform signature reflects the onset of induction chemotherapy for acute myeloid leukemia.

Anensen N, Oyan AM, Bourdon JC, Kalland KH, Bruserud O, Gjertsen BT.

Transfusion. 2006 May;46(5):800-10.

Cytokine accumulation in photochemically treated and gamma-irradiated platelet concentrates during storage.

Apelseth TO, Hervig TA, Wentzel-Larsen T, Bruserud O.

Acta Oncol. 2006;45(3):346-9.

Treatment with valproic acid, all-trans retinoic acid (ATRA) and theophyllamine for 9 days caused a persistent increase in peripheral blood platelet counts for a patient with acute myelogenous leukemia.

Stapnes C, Ryningen A, Gjertsen BT, Bruserud Ø.

Cancer. 2006 Jun 1;106(11):2397-405.

A phase II trial of pegylated interferon alpha-2b therapy for polycythemia vera and essential thrombocythemia: feasibility, clinical and biologic effects, and impact on quality of life.

Samuelsson J, Hasselbalch H, Bruserud O, Temerinac S, Brandberg Y, Merup M, Linder O, Bjorkholm M, Pahl HL, Birgegard G; Nordic Study Group for Myeloproliferative Disorders.

Cancer Immunol Immunother. 2007 Jan;56(1):13-24. Epub 2006Apr 13.

Effects of interferon gamma on native human acute myelogenous leukaemia cells.

Ersvaer E, Skavland J, Ulvestad E, Gjertsen BT, Bruserud Ø.

BMC Bioinformatics. 2006 Apr 10;7:198.

Correlation analysis of two-dimensional gel electrophoretic protein patterns and biological variables.

Van Belle W, Anensen N, Haaland I, Bruserud Ø, Høgda KA, Gjertsen BT.

Leuk Res. 2006 Dec;30(12):1531-40. Epub 2006 Apr 5.

Stress-induced in vitro apoptosis of native human acute myelogenous leukemia (AML) cells shows a wide variation between patients and is associated with low BCL-2:Bax ratio and low levels of heat shock protein 70 and 90.

Ryningen A, Ersvaer E, Øyan AM, Kalland KH, Vintermyr OK, Gjertsen BT, Bruserud Ø.

Int J Oncol. 2006 May;28(5):1065-80.

cDNA microarray analysis of non-selected cases of acute myeloid leukemia demonstrates distinct clustering independent of cytogenetic aberrations and consistent with morphological signs of differentiation.

Øyan AM, Bø TH, Jonassen I, Gjertsen BT, Bruserud Ø, Kalland KH.

Expert Opin Ther Targets. 2006 Feb;10(1):51-68.

Protein lysine acetylation in normal and leukaemic haematopoiesis: HDACs as possible therapeutic targets in adult AML.

Bruserud Ø, Stapnes C, Tronstad KJ, Ryningen A, Anensen N, Gjertsen BT.

Leukemia. 2006 Apr;20(4):734-6.

Acute myelogenous leukemia in a patient with Li-Fraumeni syndrome treated with valproic acid, theophyllamine and all-trans retinoic acid: a case report.

Anensen N, Skavland J, Stapnes C, Ryningen A, Børresen-Dale AL, Gjertsen BT, Bruserud Ø.

Cancer Immunol Immunother. 2006 Jul;55(7):830-40. Epub 2005 Nov 3.

T lymphocyte chemotactic chemokines in acute myelogenous leukemia (AML): local release by native human AML blasts and systemic levels of CXCL10 (IP-10), CCL5 (RANTES) and CCL17 (TARC).

Olsnes AM, Motorin D, Ryningen A, Zaritskey AY, Bruserud Ø.

Cancer Immunol Immunother. 2006 Feb;55(2):221-8. Epub 2005 Jul 21.

Is targeted chemotherapy an alternative to immunotherapy in chronic lymphocytic leukemia?

Bruserud Ø, Tronstad KJ, McCormack E, Gjertsen BT.

Cancer Immunol Immunother. 2006 Feb;55(2):185-7. Epub 2005 Jul 7.

Immunotherapy in chronic lymphocytic leukemia.

Bruserud Ø, McCormack E, Gjertsen BT.